Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Survival Tree01:19

Survival Tree

147
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
147
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

269
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
269
Cancer Survival Analysis01:21

Cancer Survival Analysis

434
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
434
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

289
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
289
Hazard Ratio01:12

Hazard Ratio

230
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
230
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

691
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
691

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial Intelligence-Based Feature Analysis of Pulmonary Vein Morphology on Computed Tomography Scans and Risk of Atrial Fibrillation Recurrence After Catheter Ablation: A Multi-Site Study.

Circulation. Arrhythmia and electrophysiology·2024
Same author

Transcriptomic Insights into the Atrial Fibrillation Susceptibility Locus near the <i>MYOZ1</i> and <i>SYNPO2L</i> Genes.

International journal of molecular sciences·2024
Same author

Common <i>SYNE2</i> Genetic Variant Associated With Atrial Fibrillation Lowers Expression of Nesprin-2α1 With Downstream Effects on Nuclear and Electrophysiological Traits.

Circulation. Genomic and precision medicine·2024
Same author

Effects of simvastatin on the function of splenic CD4<sup>+</sup> and CD8<sup>+</sup> T cells in sepsis mice.

Immunologic research·2018
Same author

Observation of photoassociation of ultracold sodium and cesium at the asymptote Na (3S<sub>1/2</sub>) + Cs (6P<sub>1/2</sub>).

The Journal of chemical physics·2018
Same author

A Secure Alignment Algorithm for Mapping Short Reads to Human Genome.

Journal of computational biology : a journal of computational molecular cell biology·2018
Same journal

Ensuring Quality in Preclinical Research: The Importance of Being Human.

Biometrical journal. Biometrische Zeitschrift·2026
Same journal

Addressing Cluster-Level Treatment Effect Heterogeneity in Sample Size Determination for Hierarchical 2 × 2 Factorial Designs.

Biometrical journal. Biometrische Zeitschrift·2026
Same journal

A Multiple Imputation Approach to Distinguish Curative From Life-Prolonging Effects in the Presence of Missing Covariates.

Biometrical journal. Biometrische Zeitschrift·2026
Same journal

Tests for Categorical Data Beyond Pearson: A Distance Covariance and Energy Distance Approach.

Biometrical journal. Biometrische Zeitschrift·2026
Same journal

Nonparametric Estimation of the Patient-Weighted While-Alive Estimand.

Biometrical journal. Biometrische Zeitschrift·2026
Same journal

Two-Stage Multiple Test Procedures Controlling False Discovery Rate With Auxiliary Variable and Their Application to Set4 <math><semantics><mi>Δ</mi> <annotation>$\Delta$</annotation></semantics></math> Mutant Data.

Biometrical journal. Biometrische Zeitschrift·2026
See all related articles

Related Experiment Video

Updated: Sep 2, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K

High-dimensional feature selection in competing risks modeling: A stable approach using a split-and-merge ensemble

Han Sun1,2, Xiaofeng Wang2

  • 1Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio, USA.

Biometrical Journal. Biometrische Zeitschrift
|August 8, 2022
PubMed
Summary
This summary is machine-generated.

Random Approximate Elastic Net (RAEN) offers a stable solution for variable selection in high-dimensional competing risks data. This new method improves prediction accuracy and parameter estimation, outperforming existing approaches.

Keywords:
competing risksgenomichigh dimensionalleast squares approximationvariable selection

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.6K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

Related Experiment Videos

Last Updated: Sep 2, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.6K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

Area of Science:

  • Biostatistics
  • Computational Biology
  • Genomics

Background:

  • Variable selection is crucial for high-dimensional competing risks data analysis.
  • Existing penalized and machine learning methods often lack stability in practice.
  • Addressing the large-p-small-n problem in competing risks regression is challenging.

Purpose of the Study:

  • To introduce Random Approximate Elastic Net (RAEN), a novel, stable, and generalizable method for variable selection in competing risks regression.
  • To demonstrate the applicability of RAEN to various time-to-event models, including quantile regression and accelerated failure time models.
  • To provide a user-friendly R package for the implementation of RAEN.

Main Methods:

  • RAEN utilizes a computationally intensive algorithm within a general framework.
  • The method is applied under the proportional subdistribution hazards model.
  • Simulations and a real-world cancer study were used for validation.

Main Results:

  • RAEN demonstrated markedly improved variable selection and parameter estimation compared to existing methods.
  • Extensive simulations confirmed the stability and generalizability of RAEN.
  • The method successfully identified influential genes in bladder cancer progression and death.

Conclusions:

  • RAEN provides a robust and effective solution for variable selection in high-dimensional competing risks data.
  • The proposed method enhances the reliability of statistical modeling for complex survival data.
  • RAEN has practical implications for identifying biomarkers in cancer research.